NorthWest Biotherapeutics Inc (NWBO)

[MolBiol]

I'm trying to follow your theory on AA, but it makes absolutely no sense whatsoever. Are you saying that the data accumulated thus far can be used for AA approval and then the trial continues as a post-marketing/approval commitment? You also said this previosuly:

Actually, yes it is. The verification of surrogate benefit is quite loose, and dependent upon multiple possible measurements. AA does not have to be based on statistically significant findings (p-value < 0.05), and often is not.

So basically, the surrogate data aren't required to be reliable for AA. Is that really what you are saying?